retatrutide maximum dose clinical trials VisualAbstract: reduces body weight by 17.5% in patients with obesity 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”
Description
Phase 3 trials, which are larger and longer, are required to confirm these results and to establish long-term safety before approval
Slowing stomach emptying to increase fullness and reduce appetite
Telehealth prescribing is widely available
55% increase in GLP-1 to reduce appetite and regulate blood sugar*
When I emailed Remedy, they got back to me in less than 48 hours
